Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.26 USD | +2.44% | +1.61% | -16.00% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 113M |
---|---|---|---|---|---|
Net income 2024 * | -93M | Net income 2025 * | -104M | EV / Sales 2024 * | - |
Net cash position 2024 * | 33.12M | Net Debt 2025 * | 55.55M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.28
x | P/E ratio 2025 * |
-1.27
x | Employees | 77 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.28% |
Latest transcript on Immunic, Inc.
1 day | +2.44% | ||
1 week | +1.61% | ||
1 month | -4.55% | ||
3 months | +5.88% | ||
6 months | +18.87% | ||
Current year | -16.00% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Vitt
CEO | Chief Executive Officer | 55 | 16-12-31 |
Glenn Whaley
DFI | Director of Finance/CFO | 56 | 19-11-30 |
Hella Kohlhof
CTO | Chief Tech/Sci/R&D Officer | 51 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barclay Phillips
BRD | Director/Board Member | 61 | 19-11-18 |
Tamar Howson
BRD | Director/Board Member | 75 | 19-10-10 |
Jörg Neermann
BRD | Director/Board Member | 57 | 19-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 1.26 | +2.44% | 224,863 |
24-04-29 | 1.23 | +0.82% | 170,561 |
24-04-26 | 1.22 | -3.17% | 237,436 |
24-04-25 | 1.26 | +1.61% | 244,882 |
24-04-24 | 1.24 | -.--% | 129,678 |
Delayed Quote Nasdaq, April 30, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.00% | 113M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-9.74% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- IMUX Stock